Category: Germany

To use on not to use: Attorney General Szpunar’s opinion on Viridis Pharmaceutical

The pharmaceutical industry has become increasingly more competitive. This competition causes companies to do all they can to secure the branding of their products (drugs) before they are available for commercial consumption. Consequently, it can sometimes be difficult for drug manufacturers to understand what constitutes ‘general use’ under the European Union Trade Mark Regulation (‘EUTMR’).

Read More »